Industrial - Machinery
Compare Stocks
2 / 10Stock Comparison
JBTM vs HLI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
JBTM vs HLI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Machinery | Financial - Capital Markets |
| Market Cap | $7.18B | $10.71B |
| Revenue (TTM) | $3.88B | $2.39B |
| Net Income (TTM) | $168M | $448M |
| Gross Margin | 35.3% | 38.5% |
| Operating Margin | 7.5% | 21.0% |
| Forward P/E | 16.8x | 19.9x |
| Total Debt | $1.88B | $438M |
| Cash & Equiv. | $187M | $971M |
JBTM vs HLI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| JBT Marel Corporati… (JBTM) | 100 | 167.9 | +67.9% |
| Houlihan Lokey, Inc. (HLI) | 100 | 253.7 | +153.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JBTM vs HLI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JBTM is the clearest fit if your priority is growth exposure.
- Rev growth 121.3%, EPS growth -137.4%, 3Y rev CAGR 33.7%
- 121.3% revenue growth vs HLI's 24.8%
- Lower P/E (16.8x vs 19.9x)
HLI carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 7 yrs, beta 0.94, yield 1.6%
- 6.0% 10Y total return vs JBTM's 156.3%
- Lower volatility, beta 0.94, Low D/E 20.1%, current ratio 1.38x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 121.3% revenue growth vs HLI's 24.8% | |
| Value | Lower P/E (16.8x vs 19.9x) | |
| Quality / Margins | 16.7% margin vs JBTM's 4.3% | |
| Stability / Safety | Beta 0.94 vs JBTM's 1.30, lower leverage | |
| Dividends | 1.6% yield, 7-year raise streak, vs JBTM's 0.3% | |
| Momentum (1Y) | +30.2% vs HLI's -5.1% | |
| Efficiency (ROA) | 11.9% ROA vs JBTM's 2.0%, ROIC 15.5% vs 3.7% |
JBTM vs HLI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
JBTM vs HLI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HLI leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JBTM is the larger business by revenue, generating $3.9B annually — 1.6x HLI's $2.4B. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to JBTM's 4.3%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.9B | $2.4B |
| EBITDAEarnings before interest/tax | $557M | $591M |
| Net IncomeAfter-tax profit | $168M | $448M |
| Free Cash FlowCash after capex | $317M | $739M |
| Gross MarginGross profit ÷ Revenue | +35.3% | +38.5% |
| Operating MarginEBIT ÷ Revenue | +7.5% | +21.0% |
| Net MarginNet income ÷ Revenue | +4.3% | +16.7% |
| FCF MarginFCF ÷ Revenue | +8.2% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +125.7% | +22.3% |
Valuation Metrics
JBTM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, HLI's 18.7x EV/EBITDA is more attractive than JBTM's 19.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $7.2B | $10.7B |
| Enterprise ValueMkt cap + debt − cash | $8.9B | $10.2B |
| Trailing P/EPrice ÷ TTM EPS | -139.32x | 26.37x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.81x | 19.92x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.67x |
| EV / EBITDAEnterprise value multiple | 19.79x | 18.75x |
| Price / SalesMarket cap ÷ Revenue | 1.89x | 4.48x |
| Price / BookPrice ÷ Book value/share | 1.62x | 4.84x |
| Price / FCFMarket cap ÷ FCF | 30.15x | 13.24x |
Profitability & Efficiency
HLI leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
HLI delivers a 20.1% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $4 for JBTM. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to JBTM's 0.42x. On the Piotroski fundamental quality scale (0–9), HLI scores 7/9 vs JBTM's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +3.8% | +20.1% |
| ROA (TTM)Return on assets | +2.0% | +11.9% |
| ROICReturn on invested capital | +3.7% | +15.5% |
| ROCEReturn on capital employed | +4.0% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 0.42x | 0.20x |
| Net DebtTotal debt minus cash | $1.7B | -$533M |
| Cash & Equiv.Liquid assets | $187M | $971M |
| Total DebtShort + long-term debt | $1.9B | $438M |
| Interest CoverageEBIT ÷ Interest expense | 3.83x | — |
Total Returns (Dividends Reinvested)
HLI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLI five years ago would be worth $24,153 today (with dividends reinvested), compared to $9,648 for JBTM. Over the past 12 months, JBTM leads with a +30.2% total return vs HLI's -5.1%. The 3-year compound annual growth rate (CAGR) favors HLI at 22.9% vs JBTM's 9.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.3% | -12.6% |
| 1-Year ReturnPast 12 months | +30.2% | -5.1% |
| 3-Year ReturnCumulative with dividends | +32.3% | +85.7% |
| 5-Year ReturnCumulative with dividends | -3.5% | +141.5% |
| 10-Year ReturnCumulative with dividends | +156.3% | +603.4% |
| CAGR (3Y)Annualised 3-year return | +9.8% | +22.9% |
Risk & Volatility
Evenly matched — JBTM and HLI each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLI is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than JBTM's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JBTM currently trades 81.0% from its 52-week high vs HLI's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 0.94x |
| 52-Week HighHighest price in past year | $170.19 | $211.78 |
| 52-Week LowLowest price in past year | $105.27 | $134.41 |
| % of 52W HighCurrent price vs 52-week peak | +81.0% | +72.5% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 36.6 |
| Avg Volume (50D)Average daily shares traded | 547K | 606K |
Analyst Outlook
HLI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates JBTM as "Buy" and HLI as "Buy". Consensus price targets imply 30.5% upside for JBTM (target: $180) vs 30.3% for HLI (target: $200). For income investors, HLI offers the higher dividend yield at 1.57% vs JBTM's 0.29%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $180.00 | $200.00 |
| # AnalystsCovering analysts | 2 | 15 |
| Dividend YieldAnnual dividend ÷ price | +0.3% | +1.6% |
| Dividend StreakConsecutive years of raises | 0 | 7 |
| Dividend / ShareAnnual DPS | $0.40 | $2.41 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.5% |
HLI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JBTM leads in 1 (Valuation Metrics). 1 tied.
JBTM vs HLI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is JBTM or HLI a better buy right now?
For growth investors, JBT Marel Corporation (JBTM) is the stronger pick with 121.
3% revenue growth year-over-year, versus 24. 8% for Houlihan Lokey, Inc. (HLI). Houlihan Lokey, Inc. (HLI) offers the better valuation at 26. 4x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate JBT Marel Corporation (JBTM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JBTM or HLI?
On forward P/E, JBT Marel Corporation is actually cheaper at 16.
8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — JBTM or HLI?
Over the past 5 years, Houlihan Lokey, Inc.
(HLI) delivered a total return of +141. 5%, compared to -3. 5% for JBT Marel Corporation (JBTM). Over 10 years, the gap is even starker: HLI returned +603. 4% versus JBTM's +156. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JBTM or HLI?
By beta (market sensitivity over 5 years), Houlihan Lokey, Inc.
(HLI) is the lower-risk stock at 0. 94β versus JBT Marel Corporation's 1. 30β — meaning JBTM is approximately 38% more volatile than HLI relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 42% for JBT Marel Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — JBTM or HLI?
By revenue growth (latest reported year), JBT Marel Corporation (JBTM) is pulling ahead at 121.
3% versus 24. 8% for Houlihan Lokey, Inc. (HLI). On earnings-per-share growth, the picture is similar: Houlihan Lokey, Inc. grew EPS 41. 6% year-over-year, compared to -137. 4% for JBT Marel Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JBTM or HLI?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus -1. 3% for JBT Marel Corporation — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21. 0% versus 5. 0% for JBTM. At the gross margin level — before operating expenses — HLI leads at 38. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JBTM or HLI more undervalued right now?
On forward earnings alone, JBT Marel Corporation (JBTM) trades at 16.
8x forward P/E versus 19. 9x for Houlihan Lokey, Inc. — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JBTM: 30. 5% to $180. 00.
08Which pays a better dividend — JBTM or HLI?
All stocks in this comparison pay dividends.
Houlihan Lokey, Inc. (HLI) offers the highest yield at 1. 6%, versus 0. 3% for JBT Marel Corporation (JBTM).
09Is JBTM or HLI better for a retirement portfolio?
For long-horizon retirement investors, Houlihan Lokey, Inc.
(HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 6% yield, +603. 4% 10Y return). Both have compounded well over 10 years (HLI: +603. 4%, JBTM: +156. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JBTM and HLI?
These companies operate in different sectors (JBTM (Industrials) and HLI (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
HLI pays a dividend while JBTM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.